As chronic pain continues to impact more lives than diabetes and heart disease combined, India’s healthcare system must rethink how ...

As gene therapies for thalassaemia near approval, India’s healthcare sector must build the right infrastructure, regulations, and payment models to ...

The promised Rs 10,000 crore Fund of Funds might sound impressive, but venture capital insider Shubham Jhuria warns it's insufficient ...

Cardiovascular diseases continue to be a significant health challenge worldwide, requiring continuous advancements in medical technology to enhance treatment outcomes. ...